Home > Press > Quantum dots spot epigenetic markers for early cancer detection
Jeff Wang, an associate professor of mechanical engineering, and biomedical engineering doctoral student Vasudev Bailey examine samples of modified DNA during a new test designed to detect early genetic clues linked to cancer. Photo by Will Kirk |
Abstract:
A researcher affiliated with Johns Hopkins Institute for NanoBioTechnology has developed a highly sensitive test using quantum dots to detect external chemical modifications to DNA called methylations. Alterations to DNA that do not involve a change in the genetic code, yet can influence gene expression, fall into the emerging science of epigenetics.
The nanotechnology based test for epigenetic markers could be used as an early detection method for cancer or to determine whether a particular cancer treatments is working or not. The research was performed by INBT affiliated faculty member Jeff Tza-Huei Wang, an associate professor of mechanical engineering from the Whiting School of Engineering, and Stephen Baylin, deputy director of the Johns Hopkins Kimmel Cancer Center. Their findings were published in the August 2009 issue of Genome Research. Read the full story from Johns Hopkins University News and Information here: releases.jhu.edu/2009/08/17/new-dna-test-uses-nanotechnology-to-find-early-signs-of-cancer/
####
About Johns Hopkins University
About
The Johns Hopkins Institute for NanoBioTechnology (INBT) at Johns Hopkins University brings together researchers from:Bloomberg School of Public Health, Krieger School of Arts and Sciences, School of Medicine, Applied Physics Laboratory and Whiting School of Engineering to create new knowledge and new technologies at the interface of nanoscience and medicine.
For more information, please click here
Contacts:
Institute for NanoBioTechnology
214 Maryland Hall
3400 North Charles Street
Baltimore, MD 21218
Phone: (410) 516-3423
Fax: (410) 516-2355
Copyright © Johns Hopkins University
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Quantum Dots/Rods
A new kind of magnetism November 17th, 2023
IOP Publishing celebrates World Quantum Day with the announcement of a special quantum collection and the winners of two prestigious quantum awards April 14th, 2023
Qubits on strong stimulants: Researchers find ways to improve the storage time of quantum information in a spin rich material January 27th, 2023
NIST’s grid of quantum islands could reveal secrets for powerful technologies November 18th, 2022
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||